CURIS, INC. Marketable Securities, Unrealized Gain (Loss)
CURIS, INC. (CRIS) reported Marketable Securities, Unrealized Gain (Loss) of $5.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-03-24
- CURIS, INC. marketable securities, unrealized gain (loss) for the quarter ending 2025-09-30 was $5.00K.
- CURIS, INC. marketable securities, unrealized gain (loss) for the quarter ending 2024-09-30 was -$42.00K, a 141.58% decline year-over-year.
- CURIS, INC. marketable securities, unrealized gain (loss) for the quarter ending 2024-06-30 was -$296.00K.
- CURIS, INC. marketable securities, unrealized gain (loss) for the quarter ending 2024-03-31 was $109.00K, a 44.10% decline year-over-year.
- CURIS, INC. marketable securities, unrealized gain (loss) for fiscal 2024 was -$229.00K, a 155.18% decline from fiscal 2023.
- CURIS, INC. marketable securities, unrealized gain (loss) for fiscal 2023 was $415.00K.
- CURIS, INC. marketable securities, unrealized gain (loss) for fiscal 2022 was -$77.00K.
- CURIS, INC. marketable securities, unrealized gain (loss) for fiscal 2021 was -$106.00K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2025-09-30 | $5.00K 10-Q · filed 2025-11-06 | |||
| 2024-12-31 | -$229.00K 10-K · filed 2026-03-24 | |||
| 2024-09-30 | -$42.00K 10-Q · filed 2025-11-06 | -$338.00K derived: sum of 2 quarters · filed 2025-11-06 | -$229.00K derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | -$296.00K 10-Q · filed 2025-11-06 | -$187.00K derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-03-31 | $109.00K 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | $415.00K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $101.00K 10-Q · filed 2024-11-14 | $94.00K derived: sum of 2 quarters · filed 2024-11-14 | $289.00K derived: sum of 3 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$7.00K 10-Q · filed 2024-11-14 | $188.00K derived: sum of 2 quarters · filed 2024-11-14 | ||
| 2023-03-31 | $195.00K 10-Q · filed 2024-11-14 | |||
| 2022-12-31 | -$77.00K 10-K · filed 2024-02-08 | |||
| 2022-09-30 | $76.00K 10-Q · filed 2023-11-02 | -$28.00K derived: sum of 2 quarters · filed 2023-11-02 | -$370.00K derived: sum of 3 quarters · filed 2023-11-02 | |
| 2022-06-30 | -$104.00K 10-Q · filed 2023-11-02 | -$446.00K derived: sum of 2 quarters · filed 2023-11-02 | ||
| 2022-03-31 | -$342.00K 10-Q · filed 2023-11-02 | |||
| 2021-12-31 | -$106.00K 10-K · filed 2023-03-13 | |||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | $6.00K derived: sum of 2 quarters · filed 2022-11-09 | $0.00 derived: sum of 3 quarters · filed 2022-11-09 | |
| 2021-06-30 | $6.00K 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | ||
| 2021-03-31 | -$6.00K 10-Q · filed 2022-11-09 | |||
| 2020-12-31 | -$3.00K 10-K · filed 2022-02-24 | |||
| 2011-09-30 | -$10.98K 10-Q · filed 2011-10-31 | -$28.10K derived: sum of 2 quarters · filed 2011-10-31 | -$22.64K 10-Q · filed 2011-10-31 | |
| 2011-06-30 | -$17.13K 10-Q · filed 2011-08-04 | -$11.66K 10-Q · filed 2011-08-04 | ||
| 2010-09-30 | $10.17K 10-Q · filed 2011-10-31 | $49.96K derived: sum of 2 quarters · filed 2011-10-31 | $32.96K 10-Q · filed 2011-10-31 | |
| 2010-06-30 | $39.79K 10-Q · filed 2011-08-04 | $22.79K 10-Q · filed 2011-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |